Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 18290749)

1.

The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals.

Tegger MK, Crane HM, Tapia KA, Uldall KK, Holte SE, Kitahata MM.

AIDS Patient Care STDS. 2008 Mar;22(3):233-43. doi: 10.1089/apc.2007.0092.

PMID:
18290749
2.

Chronic Pain in HIV-Infected Patients: Relationship to Depression, Substance Use, and Mental Health and Pain Treatment.

Uebelacker LA, Weisberg RB, Herman DS, Bailey GL, Pinkston-Camp MM, Stein MD.

Pain Med. 2015 Jun 27. doi: 10.1111/pme.12799. [Epub ahead of print]

PMID:
26119642
3.

HIV Screening and Access to Care: Exploring the Impact of Policies on Access to and Provision of HIV Care.

Institute of Medicine (US) Committee on HIV Screening and Access to Care.

Washington (DC): National Academies Press (US); 2011.

4.

The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.

Yang CH, Chen KJ, Tsai JJ, Lin YH, Cheng SH, Wang KF, Chiou HY.

BMC Infect Dis. 2014 Jun 4;14:304. doi: 10.1186/1471-2334-14-304.

5.

Treatment outcome of HAART-treated patients in a resource-limited setting: the Belgrade Cohort Study.

Jevtović D, Dragovic G, Salemović D, Ranin J, Kušić J, Marinković J, Djurković-Djaković O.

Biomed Pharmacother. 2014 Apr;68(3):391-5. doi: 10.1016/j.biopha.2014.01.001. Epub 2014 Jan 15.

PMID:
24486106
6.

Smear positive pulmonary tuberculosis among HIV patients receiving highly active antiretroviral therapy in Dar es Salaam, Tanzania.

Bwana V, Tenu F, Magesa SM, Mfinanga SG.

Tanzan J Health Res. 2011 Jan;13(1):14-20.

PMID:
24409642
8.

Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study.

Thorsteinsson K, Ladelund S, Jensen-Fangel S, Johansen IS, Katzenstein TL, Pedersen G, Storgaard M, Obel N, Lebech AM.

BMC Infect Dis. 2012 Nov 12;12:293. doi: 10.1186/1471-2334-12-293.

9.

Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults.

Nachega JB, Mutamba B, Basangwa D, Nguyen H, Dowdy DW, Mills EJ, Katabira E, Nakimuli-Mpungu E.

Trop Med Int Health. 2013 Jan;18(1):53-7. doi: 10.1111/tmi.12019. Epub 2012 Nov 8.

10.

Predictors of highly active antiretroviral therapy utilization for behaviorally HIV-1-infected youth: impact of adult versus pediatric clinical care site.

Agwu AL, Siberry GK, Ellen J, Fleishman JA, Rutstein R, Gaur AH, Korthuis PT, Warford R, Spector SA, Gebo KA.

J Adolesc Health. 2012 May;50(5):471-7. doi: 10.1016/j.jadohealth.2011.09.001. Epub 2011 Nov 4.

11.

Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youth.

Mellins CA, Elkington KS, Leu CS, Santamaria EK, Dolezal C, Wiznia A, Bamji M, Mckay MM, Abrams EJ.

AIDS Care. 2012;24(8):953-62. doi: 10.1080/09540121.2012.668174. Epub 2012 Apr 23.

12.

Assessment and Treatment of Patients with Coexisting Mental Illness and Alcohol and Other Drug Abuse.

Center for Substance Abuse Treatment.

Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 1994.

13.

Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans.

Nurutdinova D, Chrusciel T, Zeringue A, Scherrer JF, Al-Aly Z, McDonald JR, Overton ET.

AIDS. 2012 Jan 14;26(2):229-34. doi: 10.1097/QAD.0b013e32834e1404.

PMID:
22089375
14.
15.

Simultaneous HAART improves survival in children coinfected with HIV and TB.

Pensi T, Hemal A, Banerjee T.

Trop Med Int Health. 2012 Jan;17(1):52-8. doi: 10.1111/j.1365-3156.2011.02884.x. Epub 2011 Oct 3.

16.

Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters.

Writing Committee for the CASCADE Collaboration.

Arch Intern Med. 2011 Sep 26;171(17):1560-9. doi: 10.1001/archinternmed.2011.401.

17.

CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy.

Li X, Margolick JB, Jamieson BD, Rinaldo CR, Phair JP, Jacobson LP.

J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):421-8. doi: 10.1097/QAI.0b013e31821e9f21.

18.

A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes.

Chung MH, Richardson BA, Tapia K, Benki-Nugent S, Kiarie JN, Simoni JM, Overbaugh J, Attwa M, John-Stewart GC.

PLoS Med. 2011 Mar;8(3):e1000422. doi: 10.1371/journal.pmed.1000422. Epub 2011 Mar 1.

19.

Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant status.

Pérez-Molina JA, Suárez-Lozano I, Del Arco A, Teira R, Bachiller P, Pedrol E, Martínez-Alfaro E, Domingo P, Mariño A, Ribera E, Antela A, de Otero J, Navarro V, González-García J; Gesida 5808 Study Group.

HIV Clin Trials. 2011 Jan-Feb;12(1):1-8. doi: 10.1310/hct1201-1.

PMID:
21388936
20.

Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort.

Cescon AM, Cooper C, Chan K, Palmer AK, Klein MB, Machouf N, Loutfy MR, Raboud J, Rachlis A, Ding E, Lima VD, Montaner JS, Rourke SB, Smieja M, Tsoukas C, Hogg RS; CANOC Collaboration.

HIV Med. 2011 Jul;12(6):352-60. doi: 10.1111/j.1468-1293.2010.00890.x. Epub 2010 Nov 8.

PMID:
21059167
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk